Table 1.
Demographic and clinical characteristics of participating patients
| Czech Republic (n = 10) | Italy (n = 10) | Norway (n = 8) | Slovakia (n = 10) | Spain (n = 10) | Sweden (n = 9) | United Kingdom (n = 8) | All patients (n = 65) | |
|---|---|---|---|---|---|---|---|---|
| Age, mean years (SD) | 62.2 (7.4) | 60.8 (7.1) | 59.5 (8.9) | 59.9 (14.9) | 63.5 (11.6) | 63.1 (17.9) | NA | 61.5 (11.5) |
| Sex, n male (%) | 5 (50) | 7 (70) | 4 (50) | 4 (40) | 7 (70) | 6 (67) | 2 (25) | 35 (54) |
| Highest education level, n (%) | ||||||||
| High school only | 0 | 0 | 0 | 0 | 1 (10) | 0 | 0 | 1 (2) |
| Some college | 6 (60) | 5 (50) | 2 (25) | 6 (60) | 5 (50) | 7 (78) | 0 | 31 (48) |
| Bachelor’s degree | 1 (10) | 3 (30) | 1 (13) | 4 (40) | 3 (30) | 2 (22) | 3 (38) | 17 (26) |
| Graduate/professional school | 3 (30) | 2 (20) | 5 (63) | 0 | 1 (10) | 0 | 5 (63) | 16 (25) |
| Employment status, n (%) | ||||||||
| Employed full-time | 4 (40) | 5 (50) | 3 (38) | 3 (30) | 4 (40) | 2 (22) | 0 | 21 (32) |
| Employed part-time | 1 (10) | 0 | 0 | 0 | 0 | 1 (11) | 0 | 2 (3) |
| Self-employed | 1 (10) | 2 (20) | 0 | 1 (10) | 1 (10) | 0 | 3 (38) | 8 (12) |
| Retired | 4 (40) | 3 (30) | 4 (50) | 6 (60) | 4 (40) | 6 (67) | 5 (63) | 32 (49) |
| Unable to work | 0 | 0 | 1 (13) | 0 | 1 (10) | 0 | 0 | 2 (3) |
| Select comorbid conditions, n (%) | ||||||||
| Cardiovascular disease | 5 (50) | 6 (60) | 3 (38) | 4 (40) | 6 (60) | 6 (67) | 4 (50) | 34 (52) |
| Hypertension | 4 (40) | 3 (30) | 2 (25) | 6 (60) | 5 (50) | 9 (100) | 3 (38) | 32 (49) |
| FH | 4 (40) | 8 (80) | 4 (50) | 4 (40) | 2 (20) | 0 | 1 (13) | 23 (35) |
| Diabetes | 0 | 0 | 1 (13) | 4 (40) | 0 | 2 (22) | 0 | 7 (11) |
| Depression | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sleep apnea | 0 | 0 | 3 (38) | 0 | 0 | 0 | 0 | 3 (5) |
| Time since first statin prescription, mean years (SD) | 9.9 (9.4) | 8.5 (6.7) | 14.9 (13.9) | 6.9 (6.8) | 9.9 (11.8) | 12.2 (8.0) | 10.1 (8.4) | 10.3 (9.4) |
| Satisfaction with current treatment,a mean score (SD) [n] | 5.2 (4.9) [8] | 3.9 (3.9) [7] | 5.3 (4.5) [6] | 4.9 (3.9) [10] | 6.2 (4.4) [7] | 10.0 (0.0) [3] | 4.0 (NC) [1] | 5.4 (4.1) [42] |
| Current number of statins, n (%) | ||||||||
| 0 | 8 (80) | 5 (50) | 3 (38) | 7 (70) | 2 (20) | 8 (89) | 6 (75) | 39 (60) |
| 1 | 2 (20) | 3 (30) | 2 (25) | 3 (30) | 6 (60) | 1 (11) | 2 (25) | 19 (29) |
| 2 | 0 | 2 (20) | 3 (38) | 0 | 2 (20) | 0 | 0 | 7 (11) |
FH familial hypercholesterolemia, [n] patients with data available, NA not available, NC not calculated, SD standard deviation
aSatisfaction with treatment was scored on a numerical rating scale from 0 (not satisfied at all) to 10 (extremely satisfied)